Endo, Inc (OTCQX: NDOI) ("Endo"), announced today that one of its operating subsidiaries, Endo USA, Inc., is voluntarily recalling all lots within expiry of Adrenalin® Chloride Solution ...

--Endo, Inc. announced today that one of its operating subsidiaries, Endo USA, Inc., is expanding its previously announced voluntary recall of Clonazepam Orally Disintegrating Tablets, USP due to ...

Rani Therapeutics Holdings Inc (NASDAQ:RANI) experienced an 18% jump in its stock price following news that the ...

Drug manufacturer Endo announced on Friday that one of its operating subsidiaries, Endo USA, Inc., is expanding its previously announced voluntary recall of Clonazepam Orally Disintegrating ...

A novel AI-powered retina tracker can analyze retinal images with near-perfect accuracy in under one second, according to a study presented at ENDO 2025, the Endocrine Society's annual meeting in San ...

SOUTH SAN FRANCISCO, CA, USA I July 14, 2025 I Marea Therapeutics, Inc., a clinical-stage biotechnology company harnessing the latest advances in human ...

Endo Will Launch the Simulator at the American Urological Association (AUA) Annual Meeting MALVERN, Pa., April 24, 2025 /PRNewswire/ -- Endo, Inc. (OTCQX: NDOI) announced today the launch ...

Endo, Inc (OTCQX: NDOI) ("Endo"), announced today that one of its operating subsidiaries, Endo USA, Inc., is voluntarily recalling all lots within expiry of Adrenalin® Chloride Solution ...

(RTTNews) - Endo USA, Inc., affiliated to generics and specialty branded pharmaceutical company Endo, Inc., has expanded its recall of Clonazepam Orally Disintegrating Tablets (C-IV), according to ...

Endo, Inc. (OTCQX: NDOI) ("Endo") announced today that one of its operating subsidiaries, Endo USA, Inc., is expanding its previously announced voluntary recall of Clonazepam Orally Disintegrating ...